Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literature
2011

Corticosteroid-induced spinal epidural lipomatosis in children

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Jana C Möller, Randy Q Cron, Daniel W Young, Hermann J Girschick, Deborah M Levy, David D Sherry, Akiko Kukita, Kaoru Saijo, Frank Pessler

Primary Institution: Children's Hospital, Medical Faculty 'Carl Gustav Carus', Technical University Dresden

Hypothesis

What are the characteristics and outcomes of spinal epidural lipomatosis in pediatric patients treated with corticosteroids?

Conclusion

Pediatric spinal epidural lipomatosis can be effectively managed with corticosteroid dose reduction, leading to good outcomes.

Supporting Evidence

  • Spinal epidural lipomatosis is a rare complication of chronic corticosteroid treatment.
  • Back pain was the most common presenting symptom among the cases.
  • Most cases were diagnosed within the first 18 months of corticosteroid treatment.
  • Reducing corticosteroid doses led to remission of symptoms in most patients.

Takeaway

This study shows that kids who take steroids can sometimes get a rare condition where fat builds up in their spine, but if doctors catch it early and lower the steroid dose, they can feel better.

Methodology

The study included a case report of a new pediatric patient and a literature review of 19 other pediatric cases.

Potential Biases

Potential publication bias may affect the comprehensiveness of the findings.

Limitations

The analysis may be subject to publication bias, as cases with good outcomes may be underreported.

Participant Demographics

The average age at diagnosis was 11 years, with 55% being boys.

Digital Object Identifier (DOI)

10.1186/1546-0096-9-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication